language-icon Old Web
English
Sign In

Idraparinux

Idraparinux sodium is an anticoagulant medication in development by Sanofi-Aventis. Idraparinux sodium is an anticoagulant medication in development by Sanofi-Aventis. It has a similar chemical structure and the same method of action as fondaparinux, but with an elimination half-life about five to six times longer (an increase from fondaparinux's 17 hours to approximately 80 hours), which means that the drug should only need to be injected once a week.

[ "Warfarin", "Antithrombotic", "Thrombin", "Antithrombin", "venous thromboembolism" ]
Parent Topic
Child Topic
    No Parent Topic